This commentary complements the report from Nixon and colleagues by addressing the critical definitions, assay and analytical quality control and interpretation, and resources available to advance similar fit-for-purpose biomarker development.

See related article by Nixon et al., p. xxxx

This content is only available via PDF.
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
You do not currently have access to this content.